相关实验视频

Updated: May 27, 2025

Quantitative Determination of De Novo Fatty Acid Synthesis in Brown Adipose Tissue Using Deuterium Oxide
07:34

Quantitative Determination of De Novo Fatty Acid Synthesis in Brown Adipose Tissue Using Deuterium Oxide

Published on: May 12, 2023

961

SREBF1,多发性硬化症和冠心病的基因:基于孟德尔的随机化研究

Linqin Du1, Yangyang Cui1, Yang Zhou1

  • 1Department of Cardiology, Affiliated Hospital of North Sichuan Medical College, No. 63, Wenhua Road, Nanchong, Sichuan Province, 637000, P. R. China.

Hereditas
|February 14, 2025
PubMed
概括

对多发性硬化症 (MS) 的遗传倾向显著增加了冠心病 (CHD) 的风险. 该基因SREBF1被确定为一种潜在的治疗点,用于开发治疗MS和CHD的药物.

关键词:
生物标志物 生物标志物冠心病是一种冠心病.门德尔的随机化多发性硬化症是多发性硬化症.在SREBF1中,

更多相关视频

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.1K
Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice08:09

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Published on: March 24, 2017

8.0K

相关概念视频

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.3K